4.5 Article

Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Pharmacology & Pharmacy

Blood-Based Alzheimer's Biomarkers

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Neurosciences

Molecular Profiles of Amyloid-β Proteoforms in Typical and Rapidly Progressive Alzheimer's Disease

Aneeqa Noor et al.

Summary: This study aimed to identify the variations in Aβ proteoforms in Alzheimer's disease patients to determine if these variants may constitute strains underlying the phenotypic variability. The presence of highly hydrophobic Aβ seeds in rpAD brains that seeded reactions at a slower pace compared to typical Alzheimer's disease was validated. This suggests important points of intervention in the molecular pathways modulated by brain-derived Aβ.

MOLECULAR NEUROBIOLOGY (2022)

Review Clinical Neurology

Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review

Jetske van der Schaar et al.

Summary: The study provides an overview of considerations regarding the disclosure of AD pathology before the onset of dementia, categorizing them into clinical, personal, and societal contexts. The literature on this topic is diverse and contradictory, with a focus on harmful effects.

ALZHEIMERS RESEARCH & THERAPY (2022)

Review Clinical Neurology

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation

Charlotte E. Teunissen et al.

Summary: Recent research suggests that blood-based biomarkers for Alzheimer's disease may become a reality, with consistent results across different cohorts. Additionally, other blood-based biomarkers can provide information about disease progression and treatment effects.

LANCET NEUROLOGY (2022)

Article Neurosciences

Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study

Clinton B. Wright et al.

Summary: This study found significant race/ethnic disparities in the prevalence of mild cognitive impairment and dementia in a diverse community-based cohort in Northern Manhattan, with Hispanic participants having a higher risk. White matter hyperintensity burden was significantly associated with greater odds of MCI or dementia, but there was no significant interaction by race/ethnicity.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Article Multidisciplinary Sciences

Random forest-integrated analysis in AD and LATE brain transcriptome-wide data to identify disease-specific gene expression

Xinxing Wu et al.

Summary: Alzheimer's disease (AD) and LATE are complex neurodegenerative disorders affecting cognition and behavior. The development of drugs to target these diseases has been slow due to incomplete understanding of associated genes. Analyzing imbalanced data is challenging, but essential for identifying disease-related genes and improving potential treatment strategies.

PLOS ONE (2021)

Article Clinical Neurology

Time-to-event prediction using survival analysis methods for Alzheimer's disease progression

Rahul Sharma et al.

Summary: This study develops a survival analysis approach to predict the progression of Alzheimer's disease, providing personalized treatment recommendations based on patient profiles and critical features evaluation. The deep learning-based survival method shows promising results for efficient prediction and personalized treatment recommendations in progressive diseases like Alzheimer's disease.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Article Geriatrics & Gerontology

Incidence of Mild Cognitive Impairment, Conversion to Probable Dementia, and Mortality

Yun Zhang et al.

Summary: This study estimated the incidence of MCI, conversion to probable dementia, and mortality using multi-state survival models. The results showed associations between education level and incidence of MCI and probable dementia, with disparities in incidence among different racial and ethnic groups.

AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2021)

Article Clinical Neurology

AD risk score for the early phases of disease based on unsupervised machine learning

Zheyu Wang et al.

ALZHEIMERS & DEMENTIA (2020)

Review Clinical Neurology

State of the science on mild cognitive impairment (MCI)

Nicole D. Anderson

CNS SPECTRUMS (2019)

Article Health Care Sciences & Services

DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network

Jared L. Katzman et al.

BMC MEDICAL RESEARCH METHODOLOGY (2018)

Review Nutrition & Dietetics

Effect of dietary interventions in mild cognitive impairment: a systematic review

Andrea M. McGrattan et al.

BRITISH JOURNAL OF NUTRITION (2018)

Editorial Material Medicine, General & Internal

A New Initiative on Precision Medicine

Francis S. Collins et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Clinical Neurology

Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine

David J. Irwin et al.

ACTA NEUROPATHOLOGICA (2015)

Article Multidisciplinary Sciences

Alzheimer's disease: rapid and slow progression

Craig J. Thalhauser et al.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2012)

Article Clinical Neurology

Disease progression meta-analysis model in Alzheimer's disease

Kaori Ito et al.

ALZHEIMERS & DEMENTIA (2010)

Article Clinical Neurology

Early Diagnosis of Alzheimer's Disease: Is MCI Too Late?

Ronald C. Petersen

CURRENT ALZHEIMER RESEARCH (2009)

Editorial Material Multidisciplinary Sciences

NEUROSCIENCE Alzheimer's disease

Lennart Mucke

NATURE (2009)

Article Clinical Neurology

Whole-brain atrophy rate in Alzheimer disease - Identifying fast progressors

J. D. Sluimer et al.

NEUROLOGY (2008)

Article Geriatrics & Gerontology

Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease

Deepika Bhargava et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2006)

Article Statistics & Probability

A potential for bias when rounding in multiple imputation

NJ Horton et al.

AMERICAN STATISTICIAN (2003)

Article Clinical Neurology

A method for estimating progression rates in Alzheimer disease

RS Doody et al.

ARCHIVES OF NEUROLOGY (2001)